Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Spheroid cultures are among the most explored cellular biomaterials used in cardiovascular research, due to their improved integration of biochemical and physiological features of the heart in a defined architectural three-dimensional microenvironment when compared to monolayer cultures. To further explore the potential use of spheroid cultures for research, we engineered a novel in vitro model of the heart with vascularized cardiac spheroids (VCSs), by coculturing cardiac myocytes, endothelial cells, and fibroblasts isolated from dissociated rat neonatal hearts (aged 1-3 days) in hanging drop cultures. To evaluate the validity of VCSs in recapitulating pathophysiological processes typical of the in vivo heart, such as cardiac fibrosis, we then treated VCSs with transforming growth factor beta 1 (TGFβ1), a known profibrotic agent. Our mRNA analysis demonstrated that TGFβ1-treated VCSs present elevated levels of expression of connective tissue growth factor, fibronectin, and TGFβ1 when compared to control cultures. We demonstrated a dramatic increase in collagen deposition following TGFβ1 treatment in VCSs in the PicroSirius Red-stained sections. Doxorubicin, a renowned cardiotoxic and profibrotic agent, triggered apoptosis and disrupted vascular networks in VCSs. Taken together, our findings demonstrate that VCSs are a valid model for the study of the mechanisms involved in cardiac fibrosis, with the potential to be used to investigate novel mechanisms and therapeutics for treating and preventing cardiac fibrosis in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, cell death and disturbed vascular networks in spheroids were observed after addition of a cardiotoxic and profibrotic agent (i.e. Doxorubicin).”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
In the citing paper
“These findings demonstrate that cardiac spheroids can be used to elucidate the underlying pathways as well as therapeutics for preventing and treating cardiac fibrosis in vitro [311].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
In the citing paper
“A significant rise in collagen deposition following TGFβ1 treatment in spheroids was observed.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
Citations
Cites
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 13×
“Neonatal rat hearts contain approximately 30% CFs, 64% CMs, and 6% ECs [Banerjee et al., 2007].”
BackgroundInfluentialTransforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
Structural and functional characterisation of cardiac fibroblasts
CAMELLITI, P., BORG, T., & KOHL, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.020 · Cited by 930 · cited 3×
“Interstitial fibroblasts contribute to the biochemical, structural, and electromechanical properties of the myocardium, and are therefore are of particular interest for their major role in the development of cardiac fibrosis following their transdifferentiation into myofibroblasts [Brown et al., 2005; Camelliti et al.…”
BackgroundMethodMyofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673
Growth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647
Banerjee, I., Fuseler, J. W., Price, R. L., Borg, T. K., & Baudino, T. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00514.2007 · Cited by 629 · cited 5×
“Neonatal rat hearts contain approximately 30% CFs, 64% CMs, and 6% ECs [Banerjee et al., 2007].”
BackgroundMethodInfluentialTissue engineering of vascularized cardiac muscle from human embryonic stem cells
Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H. M., Gepstein, L., & Levenberg, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257776.05673.ff · Cited by 558 · cited 1×
“3D in vitro cocultures of isolated CMs, ECs, and CFs from different origin have been explored, using either scaffolds [Caspi et al., 2007, Tulloch et al., 2011] or a scaffold-free technique, such as spheroid cultures for regenerative medicine purposes [Stevens et al., 2009, Noguchi et al., 2016] or…”
MethodWhittaker, P., Kloner, R. A., Boughner, D. R., & Pickering, J. G. (1994) · Basic Research in Cardiology · doi:10.1007/bf00788278 · Cited by 496 · cited 2×
“We also demonstrated how VCSs are good models for the study of other fibrotic stimuli besides TGFβ1, such as DOX (at concentrations within the therapeutic range) [Wilkinson and Mawer, 1974, Eckes et al., 2011] ( Fig.”
Background
Cited by
Basic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Engineered materials for organoid systems
Kratochvil, M. J., Seymour, A. J., Li, T. L., Paşca, S. P., Kuo, C. J., & Heilshorn, S. C. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0129-9 · Cited by 414
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications
Zuppinger, C. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00087 · Cited by 171
Archer, C. R., Sargeant, R., Basak, J., Pilling, J., Barnes, J. R., & Pointon, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28393-y · Cited by 126
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
Augustine, R., Dan, P., Hasan, A., Khalaf, I. M., Prasad, P., Ghosal, K., Gentile, C., McClements, L., & Maureira, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111425 · Cited by 81
Self-citationLee, M.-O., Jung, K. B., Jo, S.-J., Hyun, S.-A., Moon, K.-S., Seo, J.-W., Kim, S.-H., & Son, M.-Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0139-6 · Cited by 72
Give them vasculature and immune cells – how to fill the gap of organoids
Yip, S., Wang, N., & Sugimura, R. (2023) · Cells Tissues Organs · doi:10.1159/000529431 · Cited by 68
“The models were further used to test for cellular toxicity and a potential mechanism of NO toxicity was discovered [Figtree et al., 2017].”
MethodLewis‐Israeli, Y. R., Wasserman, A. H., & Aguirre, A. (2021) · Biomolecules · doi:10.3390/biom11091277 · Cited by 65
Seidl, C. I., Fulga, T. A., & Murphy, C. L. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.09.001 · Cited by 57
Cartilage and bone tissue engineering using adipose stromal/stem cells spheroids as building blocks
Kronemberger, G. S., Matsui, R. A. M., Miranda, G. A. S. C., Granjeiro, J. M., & Baptista, L. S. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i2.110 · Cited by 56
Towards engineering heart tissues from bioprinted cardiac spheroids
Polonchuk, L., Surija, L., Lee, M. H., Sharma, P., Ming, C. L. C., Richter, F., Ben-Sefer, E., Rad, M. A., Sarmast, H. M. S., Shamery, W. A., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/ac14ca · Cited by 56
“Pre-vascularized spheroids retained high viability with minimal numbers of dead cells over 30 d, which supports their potential use for long term in vitro studies to model and evaluate complex conditions, such as ischemia/reperfusion injury and/or cardiac fibrosis [17].”
BackgroundSelf-citationStrobel, H. A., Moss, S. M., & Hoying, J. B. (2023) · Bioengineering · doi:10.3390/bioengineering10020124 · Cited by 53
Wei, X., Zhuang, L., Li, H., He, C., Wan, H., Hu, N., & Wang, P. (2020) · Small · doi:10.1002/smll.202005828 · Cited by 50
Photosynthetic Microorganisms for the Oxygenation of Advanced 3D Bioprinted Tissues
Ortega, J. S., Corrales-Orovio, R., Ralph, P., Egaña, J. T., & Gentile, C. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.05.009 · Cited by 47
Self-citationConsiderations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction
Sharma, P., Wang, X., Ming, C. L. C., Vettori, L., Figtree, G. A., Boyle, A., & Gentile, C. (2021) · Small · doi:10.1002/smll.202003765 · Cited by 43
Self-citationFan, S., Xiao, G., Ni, J., Zhao, Y., Du, H., Liang, Y., Lv, M., He, S., Fan, G., & Zhu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114642 · Cited by 43
Kumar, N., Sridharan, D., Palaniappan, A., Dougherty, J. A., Czirók, A., Isai, D. G., Mergaye, M., Angelos, M. G., Powell, H. M., & Khan, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.567842 · Cited by 43
“…as CVD models include: (a) hydrogelbased engineered heart tissue (Weinberger et al., 2017), (b) selfassembling spheroids formed via hanging drop method (Figtree et al., 2017), (c) cardiac cell-sheets (Shimizu et al., 2003), and (d) bioengineered scaffolds (Khan et al., 2015, 2018; Kc et al., 2019).”
MethodVascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics
Ciò, S. D., Marhuenda, E., Haddrick, M., & Gautrot, J. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-53678-w · Cited by 42
“Figtree et al. 22 created a vascularised cardiac spheroid model for cardiac fibrosis, relying on the co-culture of cardiac myocytes, endothelial cells, and fibroblasts in hanging droplets to form spheroids.”
Alternative strategies in cardiac preclinical research and new clinical trial formats
Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab075 · Cited by 36
Yoshida, S., Sumomozawa, K., Nagamine, K., & Nishizawa, M. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900060 · Cited by 34
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
Sharma, P., & Gentile, C. (2021) · Journal of Visualized Experiments · doi:10.3791/61962 · Cited by 33
Self-citationECIS based wounding and reorganization of cardiomyocytes and fibroblasts in co-cultures
Cavallini, F., & Tarantola, M. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.06.010 · Cited by 31
Methods for vascularization and perfusion of tissue organoids
Strobel, H. A., Moss, S. M., & Hoying, J. B. (2022) · Mammalian Genome · doi:10.1007/s00335-022-09951-2 · Cited by 24
“2004), cardiac tissue (Figtree et al. 2017; Pitaktong et al. 2020), dental pulp (Dissanayaka et al.”
BackgroundDissection of heterocellular cross-talk in vascularized cardiac tissue mimetics
Wagner, J. U. G., Pham, M. D., Nicin, L., Hammer, M., Bottermann, K., Yuan, T., Sharma, R., John, D., Muhly-Reinholz, M., Tombor, L., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.12.005 · Cited by 23
Михайловна, З. И., Gorkun, A. A., Джуссоева, Е. В., Kolokoltsova, T. D., Markov, D. D., Kosheleva, N. V., Morozov, S., & Saburina, I. N. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00540 · Cited by 23
“That said, more researchers are now using 3D cultures for studying different pathologies and drug testing in cardiology (Figtree et al., 2017), neurology (Hartley and Brennand, 2017; Nzou et al.”
BackgroundMulticellular 3D Models for the Study of Cardiac Fibrosis
Picchio, V., Floris, E., Derevyanchuk, Y., Cozzolino, C., Messina, E., Pagano, F., Chimenti, I., & Gaetani, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911642 · Cited by 23
Stem Cell-Derived Cardiac Spheroids as 3D In Vitro Models of the Human Heart Microenvironment
Campbell, M., Chabria, M., Figtree, G. A., Polonchuk, L., & Gentile, C. (2018) · Methods in molecular biology · doi:10.1007/7651_2018_187 · Cited by 22
Self-citationBasara, G., Bahçecioğlu, G., Ozcebe, S. G., Ellis, B. W., Ronan, G., & Zorlutuna, P. (2022) · Biophysics Reviews · doi:10.1063/5.0093399 · Cited by 21
Cardiac Tissue Engineering: Inclusion of Non-cardiomyocytes for Enhanced Features
Munawar, S., & Turnbull, I. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653127 · Cited by 20
“For example, treatment of fibroblasts with TGFβ inhibitors to prevent their transition into myofibroblast (Figtree et al., 2017; Cáceres et al., 2018), and thus avoid the pathologic fibrotic phenotype.”
MethodRuocco, G., Zoso, A., Mortati, L., Carmagnola, I., & Chiono, V. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00483 · Cited by 20
Richards, C., Sesperez, K., Chhor, M., Ghorbanpour, S. M., Rennie, C., Ming, C. L. C., Evenhuis, C. R., Nikolic, V. N., Orlić, N. K., Miković, Ž., et al. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00376-1 · Cited by 20
“For instance, cardiac fibrosis is only measurable in cardiac spheroids after 3 days of treatment with TGF-β1, while doxorubicin-mediated toxic effects can be detected after 24 days in culture [46, 70].”
BackgroundSelf-citationSharma, P., Ming, C. L. C., Wang, X., Bienvenu, L. A., Beck, D., Figtree, G. A., Boyle, A., & Gentile, C. (2022) · Biofabrication · doi:10.1088/1758-5090/ac47d8 · Cited by 20
Self-citationLuca, T., Pezzino, S., Puleo, S., & Castorina, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05547-3 · Cited by 20
Vettori, L., Sharma, P., Rnjak‐Kovacina, J., & Gentile, C. (2020) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-020-00026-5 · Cited by 19
Self-citationBłyszczuk, P., Zuppinger, C., Costa, A. D. S., Nurzyńska, D., Meglio, F. D., Stellato, M., Agarkova, I., Smith, G. L., Distler, O., & Kania, G. (2020) · Cells · doi:10.3390/cells9051270 · Cited by 18
“Previously, exogenous TGF-ß 1 has been shown to induce fibrosis in rat [17,18] or human [19] cardiac microtissue models.”
BackgroundHiramoto, K., Pai, H.-J., Ino, K., Nashimoto, Y., & Shiku, H. (2020) · Electrochimica Acta · doi:10.1016/j.electacta.2020.135979 · Cited by 18
Thal, S. C., Shityakov, S., Salvador, E., & Förster, C. Y. (2025) · Biomolecules · doi:10.3390/biom15040499 · Cited by 17
“Therefore, the development of additional models in other species is essential to advance our understanding of the pathophysiology and clinical progression of diabetes-related heart disease [31].”
Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease
Ming, C. L. C., Sesperez, K., Ben-Sefer, E., Arpon, D. R., McGrath, K. C. Y., McClements, L., & Gentile, C. (2021) · Cells · doi:10.3390/cells10040899 · Cited by 17
“Scaffold-free approaches using spheroids in hanging drop cultures provide similar advantages to EHTs and do not require the addition of foreign material for the fabrication of the cardiac tissue[89, 99].”
BackgroundSelf-citationGeneration and applications of cardiac spheroids
Idais, D., Roche, C. D., Kalogianni, G., Polonchuk, L., & Gentile, C. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00024-y · Cited by 15
Self-citationJahn, P., Karger, R. K., Khalaf, S. S., Hamad, S., Peinkofer, G., Sahito, R. G. A., Pieroth, S., Nitsche, F., Lu, J., Derichsweiler, D., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac73b5 · Cited by 14
“Figtree et al applied a similar strategy of generating cardiac microtissues in hanging drops and demonstrated formation of vessel-like structures [17].”
MethodTang, X., Zhai, T., Li, T., Jin, Y., Lei, D., Zhu, C., Qu, L., Li, Y., Wang, Y., Gu, H., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03707-1 · Cited by 13
“In contrast, 3D cell culture models, such as multicellular spheroids, more accurately replicate in vivo conditions, including cell–cell and cell–matrix interactions, diffusion gradients, and spatial organization [33].”
Wan, Y., Ding, J., Jia, Z., Hong, Y., Tian, G., Zheng, S., Pan, P., Wang, J., & Liang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32965 · Cited by 13
“Methods for organoid vascularization can be divided into two categories, one using a 3D bio-printing strategy and printing ECs along with surrounding tissues to form external vascularization, primarily for cardiac tissues [121]and brain [122].”
BackgroundCurrent Technologies Based on the Knowledge of the Stem Cells Microenvironments
Mawad, D., Figtree, G. A., & Gentile, C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69194-7_13 · Cited by 13
Self-citationVilinski-Mazur, K., Kirillov, B., Rogozin, O. A., & Kolomenskiy, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-86805-2 · Cited by 12
“While studying vascularized spheroids is fundamental for tissue engineering 77 , it introduces additional complexity, that is not necessary for our specific research objectives.”
Egloff‐Juras, C., Yakavets, I., Scherrer, V., François, A., Bezdetnaya, L., Lassalle, H., & Dolivet, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041966 · Cited by 12
Fabrication of Spheroids with Dome‐Shaped Endothelial Tube Networks by an Adhesive Culture System
Shima, F., & Makino, T. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000120 · Cited by 11
Organs in orbit: how tissue chip technology benefits from microgravity, a perspective
Jogdand, A. H., Landolina, M., & Chen, Y. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1356688 · Cited by 11
“Figtree et al. (2017) cocultured cardiac myocytes, endothelial cells, and fibroblasts to study cardiac fibrosis in vascularized cardiac spheroids.”
BackgroundLiu, Y., Zhang, Z., Li, H., Prados‐Martin, L., Li, H., Cheng, F., Tu, X., Lim, K. S., Li, W., & Wang, M. (2026) · Advanced Science · doi:10.1002/advs.74917 · Cited by 12
Soepriatna, A. H., Navarrete-Welton, A., Kim, T. Y., Daley, M. C., Bronk, P., Kofron, C. M., Mende, U., Coulombe, K. L. K., & Choi, B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280406 · Cited by 10
Development of an In Vitro 3D Model for Investigating Ligamentum Flavum Hypertrophy
Lin, C., Kuo, Y.-T., Tsao, C.-H., Shyong, Y., Shih, S.-H., & Tu, T. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00132-6 · Cited by 10
Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models
Cardona-Timoner, M., Gomes, R. N., & Nascimento, D. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073038 · Cited by 9
“They usually include CF and CM, as well as EC to account for the vascularization of the model [82].”
FXYD1 Is Protective Against Vascular Dysfunction
Bubb, K. J., Tang, O., Gentile, C., Moosavi, S. M., Hansen, T., Liu, C.-C., Bartolo, B. A. D., & Figtree, G. A. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16884 · Cited by 9
Self-citationRenal cell carcinoma organoids for precision medicine: bridging the gap between models and patients
Gao, J., Luo, H., Wang, S., Zhou, C., Li, Z., Kimhoy, C., Liang, G., & Chen, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06949-7 · Cited by 8
Wu, T., Li, B., Hao, L., Zhao, F., & Liu, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1604362 · Cited by 7
Ming, C. L. C., Pienaar, D., Ghorbanpour, S. M., Chen, H., Roberts, L. M., Cole, L., McGrath, K. C. Y., Padula, M. P., Henry, A., Gentile, C., et al. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00672-6 · Cited by 7
Self-citationCombinatorial approaches for novel cardiovascular drug discovery: a review of the literature
Brogi, S., Tabanelli, R., & Calderone, V. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2104247 · Cited by 7
“Moreover, engineered 3D organ-ona-chip models could be used to investigate pathological cardiovascular condition, such as fibrosis or thrombosis, to determine both the pathway undergoing the pathogenesis and therapeutics for preventing and treating CVDs [160,161].”
BackgroundZanetti, M., Braidotti, N., Khumar, M., Montelongo, E., Lombardi, R., Sbaizero, O., Mestroni, L., Taylor, M. R. G., Baj, G., Lazzarino, M., et al. (2024) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2024.106571 · Cited by 7
Modelling Cardiovascular Diseases Using Human Microphysiological Systems
Ribeiro, Q., Lopes, E., Ferreira, I. S., Simões, C. G., Vital, C. M., Inácio, J. M., Belo, J. A., Rybak‐Wolf, A., Marques, A. R. A., & Vieira, O. V. (2026) · BioChip Journal · doi:10.1007/s13206-025-00247-6 · Cited by 5
“These advances position them as a promising calcification –, contributing to the development and pro - gression of atherosclerosis [99, 109, 111, 112, 114].”
Myocardial Fibrosis: Cell Signaling and In Vitro Modeling
Graham, C., & Sethu, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_10 · Cited by 4
Ming, C. L. C., Patil, R., Refaat, A., Lal, S., Wang, X., & Gentile, C. (2025) · Biofabrication · doi:10.1088/1758-5090/adb7c2 · Cited by 4
“Human CSs were generated using the methodologies previously outlined [41, 42].”
Self-citationVenegas-Zamora, L., Fiedler, M. J., Perez, W., & Altamirano, F. J. (2023) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1295 · Cited by 4
TGFβ1 Regulates Cellular Composition of In Vitro Cardiac Perivascular Niche Based on Cardiospheres
Goltseva, Y., Дергилев, К. В., Boldyreva, M. A., Parfyonova, Y. V., & Beloglazova, I. B. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06142-8 · Cited by 3
Tissue organoid models and applications
Leach, T. S., Dominijanni, A. J., Murphy, S. V., & Atala, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00085-x · Cited by 3
Wang, B., Zhang, J., Jiang, J., Cheng, C., & Zhao, Y. (2026) · iScience · doi:10.1016/j.isci.2026.115519 · Cited by 2
“87 Such models support cellular physiological activity and ECM remodeling and can be used to assess therapeutic interventions.”
Chu, X., Wang, M., Qiu, X., Huang, Y., Li, T., Otieno, E., Li, N., Luo, L., & Xiao, X. (2021) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37298 · Cited by 2
Chhor, M., Barman, S., Heidari, F., Bottomley, A. L., Robson, T., McGrath, K. C. Y., & McClements, L. (2025) · Bioprinting · doi:10.1016/j.bprint.2025.e00397 · Cited by 1
Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models
Passadouro, A. S., Balfoort, B. M., Langeveld, M., van Karnebeek, C., van der Velden, J., Houtkooper, R. H., & Mosegaard, S. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00313-4 · Cited by 1
“These multi-cellular models have been applied in systems to study fi brosis in vitro (Figtree et al, 2017) and, when cultured in de fi ned ratios, they have facilitated the investigation of the biochemical interactions between cardiomyocytes, fi broblasts or endothelial cells (Burridge et al, 2014).”
Johansen, M. D., Ming, C. L. C., Hansbro, P. M., & Gentile, C. (2026) · Biofabrication · doi:10.1088/1758-5090/ae38d7 · Cited by 1
“In this study, we explored the impact of SARS-CoV-2 infection on the heart tissue utilising our 3D in vitro CS model, which recapitulates important cardiovascular disease phenotypes that are directly translatable to human patients (Figtree et al 2017, Polonchuk et al 2017, Sharma et al 2022b).”
Self-citationIn Vitro Assays Used to Analyse Vascular Cell Functions
Türkcan, A., Bernhard, D., & Meßner, B. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-12270-6_15 · Cited by 1
Unveiling human Cardiac Stem Cells role in myocardial ischemia-reperfusion injury
Reis, I. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Costa, P. G. M. C. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Hasan, A. (2020) · Spiral (Imperial College London) · doi:10.25560/88323
Application of Three-Dimensional Culture Method in the Cardiac Conduction System Research
Mishra, A. K., & Pasumarthi, K. B. S. (2022) · Methods and Protocols · doi:10.3390/mps5030050
Modern Approaches to the Creation of 2D and 3D Cellular Models for the Study of Lung Fibrosis
Tolstoluzhinskaya, A., Basalova, N. A., & Efimenko, A. Y. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x26070023
“Currently, spheroids are used as a suitable alternative for studying cell differentiation and other mechanisms of fibrogenesis in modeling fibrotic lung tissues or interactions of individual cell cultures that reflect the main mechanisms of fibrosis (Figtree et al., 2017).”
In Vitro Assays Used to Analyse Vascular Cell Functions
Kirchhoff, A., Wechselberger, C., Bernhard, D., & Meßner, B. (2024) · Learning materials in biosciences · doi:10.1007/978-3-031-64591-4_16
Heart-Derived Stromal Cells and In Vitro 3D Models in Cardiotoxicity Assessment
Sun, D., & Thankam, F. G. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_31
Lin, C.-L., Kuo, Y.-T., Tsao, C.-H., Shyong, Y.-J., Shih, S.-H., & Tu, T.-Y. (2020) · Figshare · doi:10.6084/m9.figshare.12900464
Richards, C., Sesperez, K., Chhor, M., Ghorbanpour, S. M., Rennie, C., Ming, C. L. C., Evenhuis, C., Nikolic, V. N., Orlic, N. K., Miković, Ž., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14456856
Self-citationEngineering a Biomimetic Adventitia to Model Fibrosis in a Tissue-Engineered Blood Vessel
Kepler, S. C. (2023) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Jahn, P. A. (2024) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Egloff‐Juras, C. (2021) · theses.fr (ABES) · doi:10.70675/2b95f754zcd49z46e5zb006zcd7f6a6dca87
Holotomography Reveals Protein Concentration Changes in Cardiac Spheroids under Ischemic StressPreprint
Sackho, K., Campagnolo, P., & Kim, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731124
“In cardiovascular research, cardiac spheroids incorporating cardiomyocytes, endothelial cells, and fibroblasts have been developed and characterised 8–11 .”
Metadata
- Authors
- Figtree, G. A., Bubb, K. J., Tang, O., Kizana, E., & Gentile, C.
- Affiliations
- The University of Sydney (AU)
- Venue
- Cells Tissues Organs
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 204
- Issue
- 3-4
- Pages
- 191-198
- ISSN
- 1422-6405 (ISSN-L)
- 1422-6421
- OpenAlex
- W2744628121
- Cited by
- 79
- References
- 38
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 14 · 2020: 13 · 2019: 6 · 2018: 5 · 2017: 1
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cells Tissues Organs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart Research Australia
- Heart Research Institute
- University of Sydney
- National Institutes of Health
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, hanging drop culture, cardiomyocytes, endothelial cells, fibroblasts, TGF-β1, collagen deposition, doxorubicin cardiotoxicity, apoptosis, connective tissue growth factor, fibronectin
- MeSH terms
- Animals, Extracellular Matrix, Fibrosis, Humans, Apoptosis, Imaging, Three-Dimensional, Myocytes, Cardiac, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.